CYH

Community Health Systems Inc

Add to Watchlist

Advanced Chart

2.460

-0.03(-1.205%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

2.505

Open

2.500

VWAP

2.47

Vol

1.84M

Mkt Cap

344.69M

Low

2.440

Amount

4.54M

EV/EBITDA(TTM)

8.13

Total Shares

140.12M

11.29B

EV/OCF(TTM)

22.99

P/S(TTM)

0.03

Community Health Systems, Inc. is a healthcare company. The Company’s affiliates are providers of healthcare services, developing and operating healthcare delivery systems in approximately 35 distinct markets across 14 states. The Company's subsidiaries own or lease 70 affiliated hospitals with more than 10,000 beds and operate more than 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. Its hospitals and other sites of care offer a variety of inpatient and outpatient medical and surgical services. These include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic services, psychiatric and rehabilitation services. In addition, some of its hospitals provide skilled nursing and home care services based on individual community needs.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

3.14B

-0.48%

-0.109

+262.73%

3.18B

-2.54%

0.168

-139.97%

3.00B

-2.97%

-0.288

-4.12%

Estimates Revision

The market is revising No Change the revenue expectations for Community Health Systems, Inc. (CYH) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -15.17%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-15.17%

In Past 3 Month

5 Analyst Rating

72.76% Upside

Wall Street analysts forecast CYH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CYH is 4.25 USD with a low forecast of 3.50 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

3 Hold

1 Sell

Hold

72.76% Upside

Current: 2.460

Low

3.50

Averages

4.25

High

6.00

72.76% Upside

Current: 2.460

Low

3.50

Averages

4.25

High

6.00

RBC Capital

Outperform

NULL

downgrade

$6 -> $5

2025-07-25

Reason

RBC Capital

Price Target

$6 -> $5

2025-07-25

downgrade

Outperform

NULL

Reason

RBC Capital lowered the firm's price target on Community Health to $5 from $6 and keeps an Outperform rating on the shares. RBC Capital is "disappointed" to see Community Health add to volume concerns with a weaker than expected adjusted admission print in the second quarter and tempered expectations for the rest of the year, the analyst tells investors in a research note.

Oppenheimer

Outperform

downgrade

$5 -> $4

2025-07-25

Reason

Oppenheimer

Price Target

$5 -> $4

2025-07-25

downgrade

Outperform

Reason

Oppenheimer lowered the firm's price target on Community Health to $4 from $5 and keeps an Outperform rating on the shares. The firm says the company struggled with volume/acuity trends during Q2, including softer surgical volumes at commercial/Marketplace payors, potentially due to economic or even immigration status concerns. Despite the depressed core earnings, Community Health was able to beat expectations due to the contribution of $75M of DPP not in prior guidance.

UBS

AJ Rice

Neutral

downgrade

2025-07-25

Reason

UBS

AJ Rice

Price Target

2025-07-25

downgrade

Neutral

Reason

UBS analyst AJ Rice lowered the firm's price target on Community Health to $3.20 from $3.50 and keeps a Neutral rating on the shares.

Barclays

Equal Weight

maintain

2025-07-24

Reason

Barclays

Price Target

2025-07-24

maintain

Equal Weight

Reason

Barclays lowered the firm's price target on Community Health to $3.50 from $4 and keeps an Equal Weight rating on the shares post the Q2 report. The firm says weakening consumer confidence and immigration polices drove negative same-store volumes and an EBITDA guidance cut.

Jefferies

Buy

Hold

downgrade

2025-07-24

Reason

Jefferies

Price Target

2025-07-24

downgrade

Buy

Hold

Reason

Jefferies downgraded Community Health to Hold from Buy with a price target of $3, down from $4.25. The firm says \"soft\" Q2 trends drove an EBITDA miss for the company while legislation creates earnings uncertainty going forward. Jefferies cites leverage concerns, new regulatory headwinds and management uncertainty for the downgrade.

Truist

David MacDonald

Hold

maintain

2025-07-16

Reason

Truist

David MacDonald

Price Target

2025-07-16

maintain

Hold

Reason

Truist analyst David MacDonald raised the firm's price target on Community Health to $4.25 from $3.50 and keeps a Hold rating on the shares as part of a broader research note previewing Q2 results for Healthcare Services. The quarter should reflect an ongoing mixed, sector-dependent backdrop across the firm's coverage universe with a focus on selectivity and utilization-leveraged names best positioned, and Managed Care continuing to face challenges, the analyst tells investors in a research note. Truist adds that it remains bullish on core demand drivers for the industry however and also believes that the Reconciliation Bill has provided increased clarity around regulatory framework.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Community Health Systems Inc (CYH.N) is -9.90, compared to its 5-year average forward P/E of -19.17. For a more detailed relative valuation and DCF analysis to assess Community Health Systems Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-19.17

Current PE

-9.90

Overvalued PE

48.83

Undervalued PE

-87.17

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

8.44

Current EV/EBITDA

8.08

Overvalued EV/EBITDA

9.15

Undervalued EV/EBITDA

7.72

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

0.06

Current PS

0.03

Overvalued PS

0.10

Undervalued PS

0.02